Our Experience in Treating Infantile Hemangioma: Prognostic Factors for Relapse After Propranolol Discontinuation
IHs located on the limbs demonstrated less rebound growth and a better treatment response. When oral propranolol was initiated earlier or when the target dose was 2 mg/kg/day, there was a higher rate of excellent response to treatment.
Authors
- Emily Avitan‐Hersh (ORCID: https://orcid.org/0000-0002-2154-7609)
- Hiba Zaaroura (ORCID: https://orcid.org/0000-0003-3490-9602)
- Ziad Khamaysi (ORCID: https://orcid.org/0000-0001-9586-2807)
- Afik Tibi
Institutions
- Technion – Israel Institute of Technology (IL)
- Rambam Health Care Campus (IL)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1007/s12325-024-03017-2
- Citations
- 5
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 2.86